Status:
COMPLETED
Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke
Lead Sponsor:
Pfizer
Conditions:
Cardiovascular Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To determine whether Lipitor reduces stroke, compared to placebo in patients who have had a previous stroke or transient ischemic attack.
Eligibility Criteria
Inclusion
- Previous stroke or TIA
Exclusion
- coronary heart disease
Key Trial Info
Start Date :
November 1 1998
Trial Type :
INTERVENTIONAL
End Date :
November 1 2005
Estimated Enrollment :
4732 Patients enrolled
Trial Details
Trial ID
NCT00147602
Start Date
November 1 1998
End Date
November 1 2005
Last Update
April 22 2015
Active Locations (130)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
East Gosford, New South Wales, Australia, 2250
2
Pfizer Investigational Site
Randwick, Sydney, New South Wales, Australia, 2031
3
Pfizer Investigational Site
Footscray, Victoria, Australia, 3011
4
Pfizer Investigational Site
Heidelberg Heights, Victoria, Australia, 3081